TY - GEN
T1 - Oxidative stress in subarachnoid haemorrhage
T2 - Significance in acute brain injury and vasospasm
AU - Ayer, R. E.
AU - Zhang, J. H.
N1 - Part of the Acta Neurochirurgica Supplementum book series (NEUROCHIRURGICA, volume 104) Aneurismal subarachnoid haemorrhage (SAH) is a devastating disease that is associated with significant morbidity and mortality. The mortality is approximately 50%, with 30% of survivors having significant morbidity.
PY - 2008/3/25
Y1 - 2008/3/25
N2 - Aneurismal subarachnoid haemorrhage (SAH) is a devastating disease that is associated with significant morbidity and mortality. The mortality is approximately 50%, with 30% of survivors having significant morbidity. There is substantial evidence to suggest that oxidative stress is significant in the development of acute brain injury and cerebral vasospasm following SAH. There are several sources for the excessive generation of free radicals following SAH, including disrupted mitochondrial respiration and extracellular hemoglobin. There is also the upregulation of free radical producing enzymes such as inducible nitric oxide synthase (iNOS), xanthine oxidase, NADPH oxidase (NOX), as well as enzymes involved in the metabolism of arachidonic acid. Additionally, intrinsic antioxidant systems such as superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) are inhibited. Experiments have linked free radicals to the apoptosis of neurons and endothelial cells, BBB breakdown and the altered contractile response of cerebral vessels following SAH. Antioxidant therapy has provided neuroprotection and antispasmotic effects in experimental SAH and some therapies have demonstrated improved outcomes in clinical trials. These studies have laid a foundation for the use of antioxidants in the treatment of aneurismal SAH. © 2008 Springer-Verlag.
AB - Aneurismal subarachnoid haemorrhage (SAH) is a devastating disease that is associated with significant morbidity and mortality. The mortality is approximately 50%, with 30% of survivors having significant morbidity. There is substantial evidence to suggest that oxidative stress is significant in the development of acute brain injury and cerebral vasospasm following SAH. There are several sources for the excessive generation of free radicals following SAH, including disrupted mitochondrial respiration and extracellular hemoglobin. There is also the upregulation of free radical producing enzymes such as inducible nitric oxide synthase (iNOS), xanthine oxidase, NADPH oxidase (NOX), as well as enzymes involved in the metabolism of arachidonic acid. Additionally, intrinsic antioxidant systems such as superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) are inhibited. Experiments have linked free radicals to the apoptosis of neurons and endothelial cells, BBB breakdown and the altered contractile response of cerebral vessels following SAH. Antioxidant therapy has provided neuroprotection and antispasmotic effects in experimental SAH and some therapies have demonstrated improved outcomes in clinical trials. These studies have laid a foundation for the use of antioxidants in the treatment of aneurismal SAH. © 2008 Springer-Verlag.
KW - Subarachnoid haemorrhage
KW - acute brain injury
KW - cerebral vasospasm
KW - oxidative stress
KW - Oxidative Stress/physiology
KW - Free Radicals/metabolism
KW - Subarachnoid Hemorrhage/mortality
KW - Oxyhemoglobins/metabolism
KW - Humans
KW - Vasospasm, Intracranial/physiopathology
KW - Brain Injuries/etiology
KW - Mitochondria/physiology
UR - http://www.scopus.com/inward/record.url?scp=85052610021&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052610021&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/58f47e86-8a86-3260-8f3c-e23317d4244d/
U2 - 10.1007/978-3-211-75718-5_7
DO - 10.1007/978-3-211-75718-5_7
M3 - Conference contribution
C2 - 18456995
SN - 9783211757178
SN - 978-3-211-99916-5
T3 - Acta Neurochirurgica, Supplementum
SP - 33
EP - 41
BT - Cerebral Vasospasm
PB - Springer Vienna
ER -